Revolutionizing Liver Health Assessment
Providing rapid access to FibroScan® technology to screen and monitor liver disease
At Liver Scan Direct, founded in 2013, we specialize in the assessment of liver health using FibroScan® technology. Our mission is to provide patients and their healthcare providers rapid access to FibroScan® technology to screen and monitor liver disease.
Liver diseases, including fatty liver, hepatitis B and C, and alcohol-related liver disease,
affect over 30% of the population and may lead to cirrhosis, liver failure, and liver cancer.
FibroScan® is a non-invasive device that measures liver stiffness and fatty infiltration as indicators of fibrosis (scarring) and steatosis, respectively. Liver stiffness may predict the risk of complications including liver failure, the need for transplantation, and liver cancer.
Our team of experienced, certified technicians is overseen by an internationally-recognized hepatologist and pioneer in liver health assessment to ensure accuracy of our FibroScan® examinations. Each report includes a summary of the findings, interpretation, and recommendations.
No doctor referral is necessary - any patient can contact us directly to make an appointment.
We operate clinics across Ontario and collaborate with health partners across Canada.
FibroScan® is recognized globally as the gold standard, non-invasive solution for assessment of liver fibrosis and steatosis based on more than 4,200 peer-reviewed publications.